Quarterly insight from our fixed income teams to help clients navigate the markets and opportunities ahead.
A guaranteed real return of 5.0% represents the holy grail for most investors. But, what does real return of 5.0% look like for health care institutions?
Debates abound on what to make of markets’ behavior. Here we assess the fundamentally-driven changes and outline levers that can be pulled to help close the return gap.
Each month, the Adaptive Multi-Asset Solutions Team provides an asset class outlook using option market prices to infer expected tail gains and tail losses.
Hamish Chamberlayne, Head of SRI, explains how the responsible use of plastics is an important consideration for evaluating the sustainability of a business.
The U.S. Fixed Income team discusses how the Fed’s newfound patience could help stabilize the U.S. economy and extend the economic and credit cycles.
Jennifer James, Lead Analyst within the Emerging Market Debt team, looks at the importance of China for Global growth and how policy shifts may be opening up domestic opportunities.
Jim Cielinski, Global Head of Fixed Income, provides his perspective on some of the key macroeconomic factors that are driving fixed income markets.
Shifting consumer habits are shaking up the food and beverage industry, creating the need for a selective approach when owning these traditionally defensive names.
Jenna Barnard, Co-Head of Strategic Fixed Income, explains how and why so many major central banks have been wrong footed on economic growth in their countries and around the globe.
Co-Head of Global Bonds Nick Maroutsos explains why investors should be mindful of where they hold duration exposure in light of a flattening yield curve.
Dr. Myron Scholes and Dr. Ashwin Alankar describe how successfully managing tail risks is key to maximizing terminal value.
Since the 1960s, the inversion of the Treasury curve has preceded every U.S. recession, but that doesn’t mean the latest inversion spells an imminent downturn.